Tigermed | Briefing, News, Analysis, Research, Data

Tigermed

Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.

Tigermed, founded in December, 2014 and headquartered in Hangzhou, is a contract research organization (CRO) focused on providing professional services for the entire process of clinical trials for new drug research. The founder is Ye Xiaoping. Listed on the SZSE on August 17, 2012, the company's major shareholders are Ye Xiaoping, Hong Kong Securities Clearing Co., Ltd and Cao Xiaochun. Rivals that have direct and indirect competition with Tigermed include Kintor, HitGen, Aprea Therapeutics, BridgeBio Pharma, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Generic Pharma

Founded

Dec 1, 2014

HQ location

Zhejiang, China

Legal name

Hangzhou Tigermed Consulting Co., Ltd.

Website

http://www.tigermed.net

ir@tigermed.net

Employees

1001-5000

All
News
Analysis
Research

Briefing Dec 29, 2021 09:39 AM · Healthcare | Consumer Staples

The pharmaceutical and biological sector has been heavily sold off by the main funds in the past three days

Briefing Dec 13, 2021 01:40 PM · Healthcare | Consumer Staples | Communication

"Lingjing oasis" completed ten million yuan financing

In depth

Three-dimensional landscape of genome. Image credit: National Cancer Institute/Unsplash

Healthcare

Clinical CRO Tigermed: The ‘Small and Beautiful’

In this race of pharmaceutical R&D outsourcing segment, WuXi AppTec, Pharmaron, Tigermed and Asychem are some of the major names – but which has a truly winning side?

Jun 14, 2020 11:00 AM

Briefing Nov 01, 2021 09:08 PM · Automotive | Technology | Healthcare

Tiger medicine: after the share repurchase, the total transaction amount is about 500 million yuan

Briefing Oct 19, 2021 10:11 AM · Healthcare

Cro stocks rose in early trading

Research

Healthcare, Technology, Consumer Staples

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Research

Healthcare

WIA2020 | Next 50 in Global Tech: Healthcare

Dec 09, 2020 09:39 AM

Research

Real Estate, Industrials, Financials

Tech for Global, Globalization Footprints of the Established and the New

May 29, 2020 08:30 PM

Research

Real Estate, Industrials, Financials

Low-Carbon Industry Expansion - Key Studies From Chinese Companies

May 28, 2020 12:40 PM

Briefing Sep 06, 2021 10:22 AM · Real Estate | Healthcare

Cro sector rose sharply, Medici rose more than 8%

Briefing Sep 02, 2021 02:38 PM · Technology | Healthcare

Shanghai: encourage social capital to invest in the construction of E-sports venues and accelerate brand construction and derivatives market development

Briefing Sep 01, 2021 09:49 AM · Financials | Healthcare

Elevator concept stocks rose across the board

Briefing Aug 27, 2021 07:32 PM · Financials | Healthcare

Aikang Technology: the net loss in the first half of the year was 66.7189 million yuan, from profit to loss

In depth

Healthcare

Meta-Health: New Era of Healthcare

While there are many benefits to incorporating metaverse into the health industry, we must heed its adverse effects.

Yesterday 09:49 AM

Healthcare

AI Microbiome Firm Xbiome Completes Series B with Nearly USD 100 Mn Financing

This is also one of the highest financings in the domestic microbiome industry.

Dec 22, 2021 08:53 PM

Briefing Aug 13, 2021 10:31 AM · Automotive | Technology | Healthcare

The cro sector rose collectively, and Medici rose nearly 7%

Briefing Jul 19, 2021 05:45 PM · Financials | Automotive | Technology

Samsung Xincai replied to the regulatory letter: there is no direct or indirect misappropriation of raised funds through entrusted loans

Briefing Jul 12, 2021 10:20 AM

Cro concept stocks rebounded across the board, and Boteng shares rose 14%

The biotech lab tests are in great demand. Image credit_thisisengineering/Unsplash

Healthcare

CRO Giant Tigermed’s 1H 2020 Net Profits Up 98%

Chinese CRO industry is setting off – the continued pandemic may bring the most potential to this industry.

Aug 29, 2020 09:02 PM

In depth

The research lab is the core engine in pharmaceutical. Image credit: Hans Reniers/Unsplash

Healthcare

WuXi AppTec: A Favorable Chinese Stock for MSCI and FTSE Russell

According to the latest quarterly index review, a Wuxi-based CRO company will be incorporated into the FTSE China A 50 Share Index. It has been considered a top holding by many MSCI China indexes for some time.

Jun 08, 2020 09:51 AM

Briefing Jul 06, 2021 10:59 AM · Healthcare

Blu ray development responds that Huaxia Bank and Vanke will take shares: unconfirmed market rumors

Briefing Jul 05, 2021 01:24 PM · Industrials | Consumer Discretionary | Healthcare

Zhuanzhuan group released mobile phone market in the second quarter: transaction volume of second-hand 5g mobile phone increased by 96.25% month on month

Briefing Jan 27, 2021 06:29 PM · Healthcare

Tiger pharmaceutical performance forecast: net profit in 2020 will increase by 100% - 115% year on year

Briefing Sep 03, 2020 01:27 PM · Healthcare

Tigermed Invests in Tongli Biomedical to Treat Parasitic Zoonoses

EqualOcean Analysis

EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.

Address

Beijing 9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai 2707-2708, AI Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China

New York 404 5th Ave New York, NY, 10018, USA

About